• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Amyris to Acquire OLIKA Consumer Brand, Expanding Family of Clean Consumer Brands and Accelerating Growth

Share:

June 21, 2021

Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of award-winning, clean wellness company OLIKA Inc. (OLIKA). The acquisition furthers Amyris’s growth and market leadership in clean health and beauty and complements Amyris’s family of consumer brands.

OLIKA, which means “differently” in Swedish, is transforming the hygiene category through a dedication to transparency, combining the safest, most effective ingredients and packaged in beautiful, nature-inspired design. The brand currently offers three sustainable hand sanitizer collections with six essential oil fragrances. OLIKA was the brainchild of Nic and Thorne Perkin. In 2019, the Perkins entrusted Alastair Dorward to expand and enhance the OLIKA brand, increase revenue, and develop the portfolio of products.

Prior to building a top-notch team at OLIKA, Dorward enjoyed a successful track record of commercializing innovative household, personal care, and food brands such as Method Products, Own Beauty, and Smitten Ice Cream. As the Founding CEO of Method Products, Dorward grew the iconic household brand from pre-revenue to more than $100 million in wholesale revenue. Under Dorward’s leadership, Method has also named California’s fastest-growing privately held company by Inc. and was named the top 20 most innovative companies in the world by Fast Company.

“It’s an honor and a privilege to spend the last 25 years building high-growth, clean and sustainable brands,” said Dorward. “Driving innovation within the food, household, personal care, and beauty categories is my life’s work. The latest journey with OLIKA transformed the hygiene category with a more desirable consumer experience. We are thrilled to accelerate the OLIKA mission with Amyris’s visionary clean beauty platform an invaluable pipeline of proprietary ingredients.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We are pleased to welcome the OLIKA brand and team to our consumer portfolio,” said John Melo, President and Chief Executive Officer of Amyris. “The addition of OLIKA alongside Pipette, our baby, mother, and family brand, provides us with a great opportunity to expand our offering and lead the sector in clean hand sanitizing and household cleaning products. We continue to take our proprietary lab-to-market science and technology directly to the consumer by combining our best-in-class natural, sustainably sourced ingredients with distinctive consumer-inspired brands,” continued Melo. “At Amyris, we continue to deliver on our ability to translate science into applications and products that are loved by consumers and that enable the transition of many industries to sustainable chemistry. We are excited to continue expanding our sector leadership and accelerating making the planet a healthier place for all.”

Alastair Dorward will join Amyris as the Chief Brand Officer and will work closely with the Amyris leadership team to continue redefining the standards of sustainability and efficacy in clean beauty and wellness while accelerating growth and innovation for the Amyris family of consumer brands.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CashMD Launches Next Generation Healthcare Platform, Bringing Transparency To Healthcare IndustryCashMD Launches Next Generation Healthcare Platform, Bringing Transparency To Healthcare Industry
  • Banner Health Deploys Buoy Health AI-Powered Digital Triage ToolBanner Health Deploys Buoy Health AI-Powered Digital Triage Tool
  • Incannex Completes Share Sale and Purchase Agreement to Wholly Acquire APIRx Pharmaceuticals USA, LLCIncannex Completes Share Sale and Purchase Agreement to Wholly Acquire APIRx Pharmaceuticals USA, LLC
  • Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight CancerAbsci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer
  • Wellington Partners Raises 210 Mln Euros for Fifth FundWellington Partners Raises 210 Mln Euros for Fifth Fund
  • Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BDThermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD
  • Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.
  • Personal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in OncologyPersonal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in Oncology

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications